Drug recall · July 11, 2018
Irinotecan Hydrochloride Injection recall
Why: Superpotent Drug: High out of specification assay value results for potency.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-402-05.
- Lots / codes
Lot #: 17034-1, 17035-1, 17036-1; Exp. 08/19
- Quantity
- 34964 vials
- Company
- Ingenus Pharmaceuticals Llc, Orlando, FL
- Distribution
- Nationwide in the USA
- Initiated
- June 8, 2018 · Voluntary: Firm initiated
- Classified
- June 29, 2018
- Reported
- July 11, 2018
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Irinotecan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.